Use of regular insulin U-500 in type 2 diabetes treatment with pump therapy

被引：0
|
作者：
Deberles, E. [1 ]
Hardouin, J. [2 ]
Penfornis, A. [3 ]
Cristea, A. [4 ]
Morera, J. [1 ]
Rod, A. [1 ]
Joubert, M. [1 ]
Benhamou, P. [4 ]
Reznik, Y. [1 ]
机构：
[1] Caen Univ Hosp, Diabet & Endocrinol, Caen, France
[2] Laval Hosp, Diabet & Endocrinol, Laval, PQ, Canada
[3] Corbeil Essonnes Hosp, Diabet, Corbeil Essonnes, France
[4] Grenoble Univ Hosp, Diabet, Grenoble, France
来源：
DIABETOLOGIA | 2017年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
680
引用
收藏
页码：S310 / S310
页数：1
相关论文
共 50 条
  • [41] U-500 INSULIN FOR INSULIN RESISTANCE
    BAUMANN, G
    SCHWEBKE, J
    AMERICAN JOURNAL OF MEDICINE, 1985, 79 (05): : A55 - A55
  • [42] A case series of Humulin R U-500 in insulin resistant people with type 2 diabetes
    Dashora, Umesh
    Ahmed, Suhail
    Shaiq, Syed
    Castro, Erwin
    Khan, Shahid Ahmed
    Bossman, Irene
    Sathiskumar, Pariasamy
    PRACTICAL DIABETES, 2021, 38 (06) : 16 - 22
  • [43] The use of U-500 in patients with extreme insulin resistance
    Cochran, E
    Musso, C
    Gorden, P
    DIABETES CARE, 2005, 28 (05) : 1240 - 1244
  • [44] Successful Use of U-500 Insulin with the Tandem X2 Pump with Control IQ (CIQ)
    Akcan, Tugce
    Basina, Marina
    DIABETES, 2024, 73
  • [45] Treatment patterns and outcomes before and after human regular U-500 insulin initiation via KwikPen® among US veterans with type 2 diabetes mellitus
    Chen, Jieling
    Borra, Sujana
    Fan, Ludi
    Huang, Ahong
    Patel, Dhiren
    Juneja, Rattan
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2021, 35 (10)
  • [46] U-500 Regular Insulin - Clinical experience and pharmacokinetics in obese, severely insulin-resistant type 2 diabetic patients
    Davidson, Mayer B.
    Navar, Maria D.
    Echeverry, Diana
    Duran, Petra
    DIABETES CARE, 2010, 33 (02) : 281 - 283
  • [47] Effect of Baseline Total Daily Dose on Clinical Outcomes of 2 Dosing Algorithms of Human Regular U-500 Insulin in Patients with Type 2 Diabetes
    Wysham, Carol
    Hood, Robert C.
    Warren, Mark L.
    Wang, Tao
    Jackson, Jeffrey A.
    DIABETES, 2015, 64 : A250 - A251
  • [48] OPTIMIZED HUMAN REGULAR U-500 INSULIN TREATMENT IMPROVES β-CELL FUNCTION IN SEVERELY INSULIN-RESISTANT PATIENTS WITH LONG-STANDING TYPE 2 DIABETES AND HIGH INSULIN REQUIREMENTS
    Mari, Andrea
    Rosenstock, Julio
    Ma, Xiaosu
    Li, Ying G.
    Jackson, Jeffrey A.
    ENDOCRINE PRACTICE, 2015, 21 (12) : 1344 - 1352
  • [49] HIGH-DOSE INSULIN THERAPY: IS IT TIME FOR U-500 INSULIN?
    Lane, Wendy S.
    Cochran, Elaine K.
    Jackson, Jeffrey A.
    Scism-Bacon, Jamie L.
    Corey, Ilene B.
    Hirsch, Irl B.
    Skyler, Jay S.
    ENDOCRINE PRACTICE, 2009, 15 (01) : 71 - 79
  • [50] Human regular U-500 insulin via continuous subcutaneous insulin infusion versus multiple daily injections in adults with type 2 diabetes: The VIVID study
    Grunberger, George
    Bhargava, Anuj
    Ly, Trang
    Zisser, Howard
    Ilag, Liza L.
    Malone, James
    Fan, Ludi
    Zhang, Shuyu
    Johnson, Jennal
    DIABETES OBESITY & METABOLISM, 2020, 22 (03): : 434 - 441
12345